Literature DB >> 11738733

T-cell vaccination for autoimmune disease: a panorama.

I R Cohen1.   

Abstract

T-cell vaccination refers to a form of cell therapy, usually autologous, aimed at curing or ameliorating autoimmune diseases. This review considers five questions: What is TCV? How is it done? How does it work? Why does it work? And what is its future?

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11738733     DOI： 10.1016/s0264-410x(01)00419-4

Source DB:  PubMed          Journal:  Vaccine        ISSN： 0264-410X            Impact factor:   3.641


  11 in total

Review 1.  Tregs in T cell vaccination: exploring the regulation of regulation.

Authors:  Irun R Cohen; Francisco J Quintana; Avishai Mimran
Journal:  J Clin Invest       Date:  2004-11       Impact factor: 14.808

2.  Rheumatic heart disease: 15 years of clinical and immunological follow-up.

Authors:  Roney O Sampaio; Kellen C Fae; Lea M F Demarchi; Pablo M A Pomerantzeff; Vera D Aiello; Guilherme S Spina; Ana C Tanaka; Sandra E Oshiro; Max Grinberg; Jorge Kalil; Luiza Guilherme
Journal:  Vasc Health Risk Manag       Date:  2007

3.  Circulating regulatory anti-T cell receptor antibodies in patients with myasthenia gravis.

Authors:  Florence Jambou; Wei Zhang; Monique Menestrier; Isabelle Klingel-Schmitt; Olivier Michel; Sophie Caillat-Zucman; Abderrahim Aissaoui; Ludovic Landemarre; Sonia Berrih-Aknin; Sylvia Cohen-Kaminsky
Journal:  J Clin Invest       Date:  2003-07       Impact factor: 14.808

4.  Development of CD4+ T cell lines that suppress an antigen-specific immune response in vivo.

Authors:  L Vieira de Moraes; B Sun; L V Rizzo
Journal:  Clin Exp Immunol       Date:  2003-01       Impact factor: 4.330

5.  T-cell seeding: neonatal transfer of anti-myelin basic protein T-cell lines renders Fischer rats susceptible later in life to the active induction of experimental autoimmune encephalitis.

Authors:  Ilan Volovitz; Felix Mor; Arthur Machlenkin; Athur Machlenkin; Ofir Goldberger; Yotvat Marmor; Lea Eisenbach; Irun R Cohen; Irun Cohen
Journal:  Immunology       Date:  2009-09       Impact factor: 7.397

6.  DNA vaccination with CD25 protects rats from adjuvant arthritis and induces an antiergotypic response.

Authors:  Avishai Mimran; Felix Mor; Pnina Carmi; Francisco J Quintana; Varda Rotter; Irun R Cohen
Journal:  J Clin Invest       Date:  2004-03       Impact factor: 14.808

7.  T-cell vaccination leads to suppression of intrapancreatic Th17 cells through Stat3-mediated RORγt inhibition in autoimmune diabetes.

Authors:  Min Wang; Liu Yang; Xiaoyan Sheng; Weilei Chen; Haiqing Tang; Hongguang Sheng; Beili Xi; Ying Qin Zang
Journal:  Cell Res       Date:  2011-04-26       Impact factor: 46.297

8.  T-cell receptor repertoires share a restricted set of public and abundant CDR3 sequences that are associated with self-related immunity.

Authors:  Asaf Madi; Eric Shifrut; Shlomit Reich-Zeliger; Hilah Gal; Katharine Best; Wilfred Ndifon; Benjamin Chain; Irun R Cohen; Nir Friedman
Journal:  Genome Res       Date:  2014-07-14       Impact factor: 9.043

9.  HSP60 as a target of anti-ergotypic regulatory T cells.

Authors:  Francisco J Quintana; Avishai Mimran; Pnina Carmi; Felix Mor; Irun R Cohen
Journal:  PLoS One       Date:  2008-12-24       Impact factor: 3.240

10.  T cell vaccination inhibits Th1/Th17/Tfh frequencies and production of autoantibodies in collagen-induced arthritis.

Authors:  Shan Li; Xiaoyin Niu; Yebin Xi; Shaohua Deng; Chengzhen Li; Qing Zhao; Guangjie Chen
Journal:  Clin Dev Immunol       Date:  2013-12-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.